European Spec Pharma Testing New Niches: Emerging Markets, Novel Products

Many struggling European specialty pharma companies are grappling with whether to move outside the traditional business mold by venturing beyond Europe, including into emerging markets, and how to develop differentiated products with potential for transformative growth.